ClinicalTrials.Veeva

Menu

Seizure Detection and Warning System in Epilepsy Patients

B

Brain Sentinel

Status

Completed

Conditions

Generalized Tonic-Clonic Seizures
Epilepsy

Treatments

Device: Brain Sentinel Seizure Detection and Warning System

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.

Full description

The Brain Sentinel™ Seizure Detection and Warning System is intended for monitoring children and adults with a history or significant risk of generalized tonic-clonic seizures in the home or healthcare facilities, during the titration or withdrawal of anti-epileptic drugs, and for continuous monitoring (night time or any other time of day) of individuals due to their history or risk of generalized tonic-clonic seizures. The device will withstand activities of daily living including showers and sleep.

Enrollment

11 patients

Sex

All

Ages

2 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject has a history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization.
  2. Male or female between the ages of 2-99.
  3. Has an upper arm circumference which is adequate for proper fit of the EMG monitor (at least 14cm).
  4. Be able to tolerate wearing the device on the upper arm.
  5. If female and of childbearing potential, has a negative pregnancy test.
  6. Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
  7. Subject and/or Primary Caregiver must be competent to follow all study procedures.
  8. Is able to read, speak and understand English.

Exclusion criteria

  1. Does not have a documented history of generalized seizures.
  2. The subject's upper arm circumference not adequate for proper fit of the EMG monitor (less than 14cm)
  3. Pregnant female
  4. Subject/Caregiver is unable to provide consent.
  5. Subject/Caregiver is not competent to follow home study procedures.
  6. The subject is homeless or in a home without a power supply.

Trial design

11 participants in 1 patient group

Brain Sentinel Seizure Detection and Warning System
Description:
To test the usability of the Brain Sentinel Seizure Detection and Warning System(also known as the SPEAC system) in a patient home setting.
Treatment:
Device: Brain Sentinel Seizure Detection and Warning System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems